Health Care · Biological Products, (No Diagnostic Substances) · OTC · CIK 946486 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $0.00Day +0.00%Mkt cap $71Y −97.6%Off 52W high −97.8%Vol (1Y) 344.9%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,398 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover1.0d |
| Next report (est.)2026-10-18 |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
| Earnings (TTM)-$40.0M |
| ROE−26.7% |
| ROIC−566.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−33.3% |
| 1Y−97.6% |
| 3Y−100.0% |
| 5Y−100.0% |
| 10Y−100.0% |
| Since incept. (ann.)−85.6% |
Total return through 2026-07-29 · series begins 2016-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)344.9% |
| Ann. volatility (3Y)247.4% |
| Sharpe (1Y)0.49 |
| Sharpe (3Y)−0.37 |
| Max drawdown (1Y)−98.9% |
| Max drawdown (3Y)−100.0% |
| Beta (3Y vs SPY)3.23 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
No 13F holders on file for WINT.
No reported quarters on file for WINT.
